The dating Game: when academia meets Industry

A Research Translation Committee Seminar

Join with UQDI's TRI-based A/Prof Fiona Simpson and her collaborator,Telix Pharmaceuticals' Dr Tracey Brown as they talk about their journey to commercialise a potential treatment for Adenoid Cystic Carcinoma. This project has led to further talks with Telix around where Fiona’s research interests intersect with other opportunities with Telix.

Tracey joined Telix in February 2020 as the Global Director of Clinical Operations. Over the last 25 years, Tracey has founded and acted as the Chief Scientific Officer or Chief Development Officer in several global biotechnology companies (Meditech, Alchemia and Anatara Lifesciences) and worked with European and USA biotechnology companies to lead product development, taking products from conception through to registration. Through this process, Tracey has developed broad-ranging experience in the manufacture of chemical and biological therapeutics, development and implementation of preclinical and clinical development plans, regulatory affairs via interaction with international regulatory agencies and management of clinical trials (Phase I-III). Tracey obtained her PhD in Biochemistry and Molecular Biology from Monash University and is a Graduate of the Australian Institute of Company Directors.

Fiona has spent more than 25 years working to create drugs that can treat deadly cancers. Her team is working on therapies for breast cancer, head and neck cancer, adenoid cystic carcinoma, prostate cancer and pancreatic cancer.

Speakers

A/Prof Fiona Simpson
Principal Research Fellow,
The University of Queensland Diamantina Institute

Dr Tracey Brown
Global Senior Vice President –Product Portfolio Management,

Telix Pharmaceuticals Research Translation Seminar 

Postponed